2003
DOI: 10.1067/mjd.2003.438
|View full text |Cite
|
Sign up to set email alerts
|

Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
77
1
3

Year Published

2004
2004
2022
2022

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 71 publications
(84 citation statements)
references
References 5 publications
3
77
1
3
Order By: Relevance
“…According to the Dsg compensation hypothesis, such patients should have acantholysis involving all epidermal layers as the adhesion properties of both molecules would be blocked. One cannot argue that the Dsg 1 antibodies are present in low and, thus, ineffective levels because their levels can be as high or higher than those against Dsg 3 [13][14][15] ; nor that the anti-Dsg 1 antibodies are directed against nonpathogenic epitopes as anti-Dsg 1 isolated from patients with PV causes acantholysis in neonatal mice. 16 Both observations point to factors other than Dsg compensation as being involved in the localization of PV lesions to basal cells.…”
Section: The Restriction Of Acantholysis To the Basal Layer In Pv Doementioning
confidence: 91%
“…According to the Dsg compensation hypothesis, such patients should have acantholysis involving all epidermal layers as the adhesion properties of both molecules would be blocked. One cannot argue that the Dsg 1 antibodies are present in low and, thus, ineffective levels because their levels can be as high or higher than those against Dsg 3 [13][14][15] ; nor that the anti-Dsg 1 antibodies are directed against nonpathogenic epitopes as anti-Dsg 1 isolated from patients with PV causes acantholysis in neonatal mice. 16 Both observations point to factors other than Dsg compensation as being involved in the localization of PV lesions to basal cells.…”
Section: The Restriction Of Acantholysis To the Basal Layer In Pv Doementioning
confidence: 91%
“…In (PV) patients showing both mucous membrane and skin involvement, Abs to both Dsg 3 and Dsg 1 may be detected (2,16,17). However, there are also cases where the Ab profile against Dsg 1 and 3 in PV does not strictly correlate with these clinical phenotypes (18,19). At present, direct evidence that the presence of Dsg 3-specific Abs in PV but not in PF may account for the more severe clinical phenotype of PV compared with PF patients is lacking.…”
mentioning
confidence: 98%
“…8 ACh signaling in keratinocytes linked to the regulation of expression and function of adhesion molecules and cholinergic drugs affects cell shape, adhesion, and cytoplasm motility (reviewed by Grando 49 ). Because of the lack of a strong correlation between the clinical phenotype of PV and the presence of anti-desmoglein 1 and 3 antibodies 50 and since PV-like lesions can be induced in neonatal mice in the absence of these antibodies, 9 the immunopathogenesis of PV can be explained through the "multiple hit" hypothesis. We propose that acantholysis in PV results from synergistic and cumulative effects of autoantibodies targeting keratinocyte cell membrane antigens of different kinds, including (1) molecules that regulate cell shape and adhesion (eg, ACh receptors) and (2) molecules that mediate cell-tocell adhesion (eg, desmosomal cadherins).…”
Section: Commentmentioning
confidence: 99%